Cargando…

OR34-1 Regulation of Breast Cancer Stem Cells by Nuclear Receptor Co-Regulatory Proteins

Despite highly effective treatments for breast cancer (BC), recurrence remains a significant risk among node-positive patients. Breast cancer stem or stem-like progenitor cells (BCSCs herein) are non-proliferative, evade first-line therapies in resistant breast tumors, and account for high mortality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ostrander, Julie, Truong, Thu, Benner, Elizabeth, Lange, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554840/ http://dx.doi.org/10.1210/js.2019-OR34-1

Ejemplares similares

OR05-04 Steroid Receptor Co-Activators Complexes Cooperate with Progesterone Receptors (PR) to Reprogram Metabolic Pathways that Drive Therapy Resistant Populations in ER+ Breast Cancer
por: Truong, Thu H, et al.
Publicado: (2020)

OR16-2 Steroid Receptor Co-Activator Complexes Regulate Metabolic PFKFB Enzymes to Drive Therapy Resistant ER+ Breast Cancer
por: Benner, Elizabeth, et al.
Publicado: (2022)

Steroid Receptor Co-Activators Regulate Metabolic Kinases to Drive Therapy Resistant ER+ Breast Cancer
por: Truong, Thu Ha, et al.
Publicado: (2021)

THU556 Targeting Breast Cancer Stem Cells With Oncolytic Virus
por: Roman Ortiz, Natasha Ivelisse, et al.
Publicado: (2023)

Targeting steroid receptor co-activators to inhibit breast cancer stem cells
por: Truong, Thu H., et al.
Publicado: (2018)

THU477 Drivers Of Estrogen Induced Invasive Lobular Carcinoma
por: Ufondu, Chinasa, et al.
Publicado: (2023)

OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
por: Hickey, Theresa E, et al.
Publicado: (2020)

OR34-3 The Androgen Receptor Malignancy Shift Can Be Caused by Mutations Commonly Found in Primary Prostate Cancer
por: Copeland, Ben, et al.
Publicado: (2019)

ODP647 Nuclear ERα and NAMPT Crosstalk in Metastatic Breast Tumors
por: Mogol, Ayca, et al.
Publicado: (2022)

Thyroid Hormone and Estrogen Promote Endocrine Resistance, Proliferation, Dedifferentiation, and Cancer Stem Cells in Steroid Receptor-Positive Breast Cancers
por: Wahdan-Alaswad, Reema S, et al.
Publicado: (2021)

OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

Nuclear ErbB-2-Induced Transcriptome Drives Triple Negative Breast Cancer Growth
por: Chervo, Maria F, et al.
Publicado: (2021)

SAT-133 Breast Tumor Kinase (Brk/PTK6) Mediates Triple Negative Breast Cancer Cell Migration and Taxol Resistance via SH2 Domain-Dependent Activation of RhoA and AhR
por: Dwyer, Amy Renee, et al.
Publicado: (2020)

THU492 Functional Characterization Of Nuclear-enriched Non-coding Genes In Triple-negative Breast Cancer
por: Reid, Victoria A, et al.
Publicado: (2023)

SAT-151 Regulation of Low-Density Lipoprotein Receptor Expression in Triple Negative Breast Cancer
por: Scully, Tiffany, et al.
Publicado: (2020)

OR05-01 Myeloid Cell Intrinsic NR0B2 Inhibits Regulatory T Cell Expansion Within The Tumor Microenvironment: Potential Novel Strategy For Breast Cancer Immunotherapy
por: Vidana Gamage, Hashni Epa, et al.
Publicado: (2023)

THU486 Identification Of Metabolic And Molecular Mechanisms Driving Estrogen Receptor Positive Breast Cancer Disparities Using A Machine-Learning Pipeline
por: Casiano, Ashlie Santaliz, et al.
Publicado: (2023)

SAT-130 The Intermediate Prolactin Receptor Is a Breast Cancer Oncogene
por: Grible, Jacqueline M, et al.
Publicado: (2020)

ODP571 Blockade of ErbB-2 Nuclear Function Induces the Interferon Signaling Pathway in Breast Cancer Models Resistant to Trastuzumab
por: Elizalde, Patricia V, et al.
Publicado: (2022)

SAT-331 Elucidating the Role of Breast Cancer Specific GATA3 Mutation in Estrogen Receptor Positive Breast Cancer
por: Lofgren, Kristopher, et al.
Publicado: (2019)

THU493 The Role Of Liver Receptor Homolog1 (LRH-1) In Regulating Breast Cancer Progression By Modulating The Immune Response
por: Wang, Yu, et al.
Publicado: (2023)

SAT-123 Nuclear Receptor 4A1 (NR4A1) Acts as a Tumor Suppressor in Anaplastic Thyroid Cancer
por: Guan, Hongyu, et al.
Publicado: (2020)

OR34-6 A Novel Mechanism of SDH-Deficient Tumorigenesis and Implications for Genetic Testing in Patients with Pheochromocytoma-Paraganglioma
por: De Sousa, Sunita M.C., et al.
Publicado: (2019)

OR34-4 ATF3 Is A Converging Point For AR Signaling And Fatty Acid Oxidation In Prostate Cancer
por: Joshi, Molishree, et al.
Publicado: (2019)

SUN-122 Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes
por: Madera, Santiago, et al.
Publicado: (2020)

OR34-5 Infiltrating Neutrophils and Neutrophil Elastase (NE) Promote Tumor Growth in a Mouse Model for Lymphangioleiomyomatosis (LAM)
por: Taya, Manisha, et al.
Publicado: (2019)

SAT635 Role Of The Human Prolactin Receptor I-tail In The Pathogenesis Of Breast Cancer
por: Clevenger, Charles V, et al.
Publicado: (2023)

SUN-131 The Roles of Two Insulin Receptor Isoforms in Triple Negative Breast Cancer Growth
por: Kang, Chifei, et al.
Publicado: (2020)

OR05-01 Small Heterodimer Partner Modulates Antigen Presenting Myeloid Cells to Impair Regulatory T Cell Expansion, Promoting Anti-Tumor Immunity in Models of Breast Cancer
por: Shahoei, Sayyed Hamed, et al.
Publicado: (2020)

MON-325 Co-Occurrence of Breast Cancer and Neuroendocrine Tumors: More Than a Coincidence?
por: Larouche, Vincent, et al.
Publicado: (2019)

ODP540 Aromatase interacting partner in Breast (AIPB) regulates estradiol in human breast
por: Moffitt, Alyssa M, et al.
Publicado: (2022)

THU554 Unconventional Estrogen Receptor Antagonists Reveal Cryptic Therapeutic Anti-breast Cancer Transcriptional Pathways
por: Hancock, Govinda, et al.
Publicado: (2023)

Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway
por: Iwabuchi, Erina, et al.
Publicado: (2021)

SAT-341 Pharmacology and Metabolism of GLL398 an Oral Selective Estrogen Receptor Degrader for Endocrine Therapy of Breast Cancer
por: Guo, Shanchun, et al.
Publicado: (2019)

THU545 Growth Hormone Receptor Antagonist As A Novel Combination Therapy Against Triple Negative Breast Cancer
por: Mora-Criollo, Patricia, et al.
Publicado: (2023)

OR05-02 The IGFBP-3/IGFBP-3 Receptor Axis Is a New Therapeutic Target for Triple Negative Breast Cancer
por: Cai, Qing, et al.
Publicado: (2020)

MON-LB053 Involvement of Stromal Age in Breasts Cancer Endocrine Response
por: Cavalier, Maryn, et al.
Publicado: (2019)

SAT-335 Resistin Induces Epithelial to Mesenchymal Transition (EMT) in Breast Cancer Cells through Activation of AXL Tyrosine Kinase Receptor
por: Weber, Daniel, et al.
Publicado: (2019)

OR16-1 How Strong and Sustained Activation of the Estrogen Receptor-mediated Anticipatory Unfolded Protein Response Kills Breast and Ovarian Cancer Cells
por: Boudreau, Matthew, et al.
Publicado: (2022)

THU481 Glucocorticoid Regeneration By Tumor Cells Promotes Growth By Enhancing Regulatory T Cell Immunosuppression
por: Taves, Matthew D, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_akv8p2mesmjap6sim1fl4n14r4